First-line zolbetuximab plus mFOLFOX6 in claudin-18 isoform 2-positive gastric and gastroesophageal junction adenocarcinoma: positioning SPOTLIGHT in the immunotherapy era

Chinese Clinical Oncology 2026 Open access

Read full text

Authors: Shigenori Kadowaki

DOI: 10.21037/cco-2025-1-167

Cited by: 0

Fields of Study & Subjects

Gastric Cancer Management and Outcomes Colorectal Cancer Treatments and Studies Esophageal Cancer Research and Treatment